Table 2 Associations of mutations with clinicopathological characteristics.

From: Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel

Variables

Mutational status

Total N

OR

95% CI

P-value

Wildtype N (%)

Mutated N (%)

BRAF

50 (50%)

50 (50%)

    

Histological subtype

LMM

5 (55.6)

4 (44.4)

9

0.5

0.2–0.8

0.013

SSM

29 (41.2)

40 (54.8)

69

   

NM

8 (57.1)

6 (42.9)

14

   

ALM

8 (100)

0 (0)

8

   

KIT

95 (95%)

5 (5%)

    

Histological subtype

LMM

9 (100)

0 (0)

9

   

SSM

68 (98.5)

1 (1.5)

69

4.4

1.6–12.1

0.004

NM

13 (92.9)

1 (7.1)

14

   

ALM

5 (62.5)

3 (37.5)

8

   

Ulceration

No

73 (98.6)

1 (1.4)

74

13.3

1.4–124.9

0.024

Yes

22 (84.6)

4 (15.4)

26

   

Tumor stage

I–II

79 (97.5)

2 (2.5)

81

7.4

1.1–47.9

0.036

III–IV

16 (84.2)

3 (15.8)

19

   

PREX2

86 (86%)

14 (14%)

    

Mitosis

<1

45 (93.8)

3 (6.3)

48

4.0

1.0–15.4

0.042

≥1

41 (78.8)

11 (21.2)

52

   

GRIN2A

87 (87%)

13 (13%)

    

Sun related site

Non exposed

20 (95.2)

1 (4.8)

21

   

Ocasionally exposed

56 (88.9)

7 (11.1)

63

3.2

1.1–9.2

0.026

Usually exposed

11 (68.8)

5 (31.3)

16

   

Mitosis

<1

46 (95.8)

2 (4.2)

48

6.2

1.3–29.5

0.023

≥1

41 (78.8)

11 (21.2)

52

   

RAC1

92 (92%)

8 (8%)

    

Sun related site

Non exposed

21 (100)

0 (0)

21

   

Ocasionally exposed

59 (93.7)

4 (6.3)

63

5.9

1.5–23.2

0.011

Usually exposed

12 (75)

4 (25)

16

   

NF1

92 (92%)

8 (8%)

    

Breslow

≤1

45 (95.7)

2 (4.3)

47

   

1–2

21 (100)

0 (0)

21

2.2

1.1–4.3

0.025

2–4

15 (78.9)

4 (21.1)

19

   

>4

10 (76.9)

3 (23.1)

13

   

Ulceration

No

72 (97.3)

2 (2.7)

74

26.9

3.1–232.1

0.003

Yes

19 (73.1)

7 (26.9)

26

   

Growth rate

SGM

74 (97.3)

2 (2.7)

76

12.2

2.3–65.4

0.004

FGM

17 (70.8)

7 (29.2)

19

   
  1. LMM: Lentigo maligna melanoma; SSM: Superficial spreading melanoma; NM: Nodular melanoma; ALM: Acral lentiginous melanoma; SGM: Slow growing melanoma; FGM: Fast growing melanoma.